Literature DB >> 3812716

Rat cardiac myocyte adenosine transport and metabolism.

D A Ford, M J Rovetto.   

Abstract

Based on the importance of myocardial adenosine and adenine nucleotide metabolism, the adenosine salvage pathway in ventricular myocytes was studied. Accurate estimates of transport rates, separate from metabolic flux, were determined. Adenosine influx was constant between 3 and 60 s. Adenosine metabolism maintained intracellular adenosine concentrations less than 10% of the extracellular adenosine concentrations and thus unidirectional influx could be measured. Myocytes transported adenosine via saturable [Michaelis constant = 6.2 +/- 2.1 microM and maximal velocity (Vmax) = 9.58 +/- 0.98 X 10(-1) pmol X mg protein-1 X s-1] and nonsaturable (rate constant = 1.8 X 10(-3)/s) processes. A minimum estimate of the Vmax of myocytic adenosine kinase (2 pmol X mg protein-1 X s-1) indicated the saturable component of adenosine influx was independent of adenosine kinase activity. Saturable transport was inhibited by nitrobenzylthioinosine and verapamil (inhibitor constant = 17 +/- 5 microM). Extracellular adenosine taken up by myocytes was rapidly phosphorylated to adenine nucleotides. Not all extracellular adenosine, though, was phosphorylated on entering myocytes, since free, as opposed to protein-bound, intracellular adenosine was detected after digitonin extraction of cells in the presence of 1 mM ethylene-diaminetetraacetic acid.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3812716     DOI: 10.1152/ajpheart.1987.252.1.H54

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

Review 1.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

2.  Heterogeneity of nucleoside transport inhibitory sites in heart: a quantitative autoradiographical analysis.

Authors:  F E Parkinson; A S Clanachan
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

3.  Extracellular formation and uptake of adenosine during skeletal muscle contraction in the rat: role of adenosine transporters.

Authors:  J Lynge; C Juel; Y Hellsten
Journal:  J Physiol       Date:  2001-12-01       Impact factor: 5.182

4.  Capacitative Ca(2+) entry in vascular endothelial cells is mediated via pathways sensitive to 2 aminoethoxydiphenyl borate and xestospongin C.

Authors:  Nour B Bishara; Timothy V Murphy; Michael A Hill
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

5.  Ca2+-antagonists inhibit the N-methyltransferase-dependent synthesis of phosphatidylcholine in the heart.

Authors:  P S Tappia; K Okumura; K Kawabata; K R Shah; M S Nijjar; V Panagia; N S Dhalla
Journal:  Mol Cell Biochem       Date:  2001-05       Impact factor: 3.396

6.  TLR4 mutation and HSP60-induced cell death in adult mouse cardiac myocytes.

Authors:  J P Heiserman; L Chen; B S Kim; S C Kim; A L Tran; N Siebenborn; A A Knowlton
Journal:  Cell Stress Chaperones       Date:  2015-02-27       Impact factor: 3.667

7.  Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency.

Authors:  C J Meininger; R S Marinos; K Hatakeyama; R Martinez-Zaguilan; J D Rojas; K A Kelly; G Wu
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

8.  ATP and other adenine compounds increase mechanical activity and inositol trisphosphate production in rat heart.

Authors:  A Legssyer; J Poggioli; D Renard; G Vassort
Journal:  J Physiol       Date:  1988-07       Impact factor: 5.182

9.  Hyperthyroidism increases adenosine transport and metabolism in the rat heart.

Authors:  R T Smolenski; M H Yacoub; A M Seymour
Journal:  Mol Cell Biochem       Date:  1995-02-23       Impact factor: 3.396

10.  Adenine nucleotide degradation in cultured chick heart muscle cells.

Authors:  B Wagenknecht; M Lieberman
Journal:  Mol Cell Biochem       Date:  1991-10-16       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.